Loading the SOTA2 catalog…
iCAD, Inc.
Global leader in AI-powered breast health solutions, now part of DeepHealth, providing clinically proven solutions for cancer detection, density assessment, and personalized risk evaluation.
- Founded
- Not disclosed
- Headquarters
- Not disclosed
- Company size
- Not disclosed
- Products tracked
- 6
Products by iCAD, Inc.
Pricing for iCAD, Inc.
Contact sales
Contact iCAD, Inc. for current plans, volume pricing, and enterprise terms.
Trust profile
Security and compliance
No compliance claims have been published for this company.
Latest updates from iCAD, Inc.
Product launch
DeepHealth Receives FDA Clearances for Breast Imaging AI Tools
DeepHealth, a subsidiary of RadNet, Inc., received FDA 510(k) clearances for two new functionalities within its Breast Suite: a Breast Arterial Calcification (BAC) Assessment tool to identify indicators of cardiovascular disease, and prior exam integration for its Mammo Dx platform to improve lesion tracking. These tools are designed to assist radiologists by providing automated assessments during standard breast imaging and are now commercially available in the United States.
